These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28693233)

  • 1. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
    Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
    Oncol Lett; 2017 Jul; 14(1):776-786. PubMed ID: 28693233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
    Ishikawa N; Hattori N; Yokoyama A; Kohno N
    Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
    Shigemura M; Nasuhara Y; Konno S; Shimizu C; Matsuno K; Yamguchi E; Nishimura M
    J Transl Med; 2012 Jul; 10():111. PubMed ID: 22650152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum KL-6 concentrations are associated with molecular sizes and efflux behavior of KL-6/MUC1 in healthy subjects.
    Shigemura M; Konno S; Nasuhara Y; Shijubo N; Shimizu C; Nishimura M
    Clin Chim Acta; 2013 Sep; 424():148-52. PubMed ID: 23778023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
    Mostafa AI; Salem AE; Ahmed HAM; Bayoumi AI; Halim RMA; Samie RMA
    Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):200-208. PubMed ID: 33840176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma.
    Stockhammer P; Baumeister H; Ploenes T; Bonella F; Theegarten D; Dome B; Pirker C; Berger W; Hegedüs L; Baranyi M; Schuler M; Deshayes S; Bölükbas S; Aigner C; Blanquart C; Hegedüs B
    Lung Cancer; 2023 Nov; 185():107360. PubMed ID: 37713954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum KL-6 levels predict clinical outcomes and are associated with
    Azekawa S; Chubachi S; Asakura T; Namkoong H; Sato Y; Edahiro R; Lee H; Tanaka H; Otake S; Nakagawara K; Fukushima T; Watase M; Sakurai K; Kusumoto T; Masaki K; Kamata H; Ishii M; Hasegawa N; Okada Y; Koike R; Kitagawa Y; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K;
    BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37230764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
    Seko A; Ohkura T; Ideo H; Yamashita K
    Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
    Yu JF; Jin YB; He J; An Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical Analysis of Krebs von den Lungen-6 (KL-6) Expression in Lung Tissue in Primary Lung Cancer Patients with High Serum KL-6 Levels].
    Yatsuyanagi E; Sato K; Sato K
    Kyobu Geka; 2015 Sep; 68(10):815-9. PubMed ID: 26329623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality.
    Scarpati G; Baldassarre D; Boffardi M; Calabrese V; De Robertis E; Lacava G; Oliva F; Pagliano P; Pascale G; Tripepi GL; Piazza O
    J Anesth Analg Crit Care; 2022 Aug; 2(1):37. PubMed ID: 37386665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia.
    Zhu Y; Fu J; You K; Jin L; Wang M; Lu D; Xue X
    Exp Lung Res; 2013 Dec; 39(10):417-26. PubMed ID: 24298937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
    Kurosaki A; Hasegawa K; Kato T; Abe K; Hanaoka T; Miyara A; O'Shannessy DJ; Somers EB; Yasuda M; Sekino T; Fujiwara K
    Int J Cancer; 2016 Apr; 138(8):1994-2002. PubMed ID: 26595060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mucin-1 568 adenosine to guanine polymorphism influences serum Krebs von den Lungen-6 levels.
    Janssen R; Kruit A; Grutters JC; Ruven HJ; Gerritsen WB; van den Bosch JM
    Am J Respir Cell Mol Biol; 2006 Apr; 34(4):496-9. PubMed ID: 16357367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.